Welcome to the Cymra Investor
Cymra Life Sciences is a pharmaceutical company that possesses prospective regulatory licenses and permits, aims to become a leading and trusted medicinal cannabis brand in chronic and neuropathic pain globally.
Cymra has been granted all required Office of Drug Control (ODC) licenses including Cultivation, Manufacturing and Export licenses (through our partner).
We focus on two key areas that are high value parts of the supply chain in pharmaceutical and where we have significant commercial expertise and advantage.
1. Genetic Licensing and Tissue Culture
2. Pharmaceutical Product Development Pipeline – chronic and neuropathic pain focused.
Cymra Life Sciences has an experienced Board and highly skilled Management with relevant industry experience.